Publications by authors named "Michael Loebinger"

Claim this Profile
U
Upper-Airway Microbiome, Mucociliary Function, and Clinical Outcomes in Bronchiectasis: Data from the EMBARC-BRIDGE Study.
Hayoung Choi, Hollian Richardson, Chandani Hennayake, Morven Shuttleworth, Erin Cant, Michael R Loebinger

Am J Respir Crit Care Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Respiratory Society clinical practice guideline for the management of adult bronchiectasis.
James D Chalmers, Charles S Haworth, Patrick Flume, Merete B Long, Pierre-Régis Burgel, Michael R Loebinger

Eur Respir J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncoding DNA Variants Increase the Genetic Diagnostic Yield in Primary Ciliary Dyskinesia.
Lizi Briggs, Cátia Brandão, Andrew Fleming, Matthew Edwards, Steven Mueller, Michael Loebinger

Am J Respir Crit Care Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus on Management of Refractory Nontuberculous Mycobacterial Pulmonary Disease.
Diana Moreira-Sousa, Beatriz Martins, Ana Aguiar, Marina Pinheiro, Onno Akkerman, Michael R Loebinger

Eur Respir J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study.
Oriol Sibila, Jamie Stobo, Lidia Perea, Yong-Hua Gao, Jin-Fu Xu, Michael R Loebinger

Lancet Respir Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertonic Saline or Carbocisteine in Bronchiectasis.
Judy M Bradley, Brenda O'Neill, Daniel F McAuley, James D Chalmers, Anthony De Soyza, Michael R Loebinger

N Engl J Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-derived biomarkers in bronchiectasis: identifying a common therapeutic target.
James D Chalmers, Marcus A Mall, Kim G Nielsen, Anne B Chang, Stefano Aliberti, Michael R Loebinger

Eur Respir J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sputum metagenomics in bronchiectasis reveals pan-European variation: an EMBARC-BRIDGE study.
Kai Xian Thng, Pei Yee Tiew, Micheál Mac Aogáin, Jayanth Kumar Narayana, Tavleen Kaur Jaggi, Michael R Loebinger

Eur Respir J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of Serum Antiglycopeptidolipid Core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.
Hayoung Choi, Chloe Hughes, Zsofia Eke, Morven Shuttleworth, Michal Shteinberg, Michael R Loebinger

Chest· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial.
Emma D Johnson, Merete B Long, Lidia Perea, Vivian H Shih, Carlos Fernandez, Michael R Loebinger

Am J Respir Crit Care Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Jennifer Pollock, Eva Polverino, Raja Dhar, Katerina Dimakou, Letizia Traversi, Michael R Loebinger

Thorax· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary ciliary dyskinesia: Aetiology, diagnosis and clinical management.
Rachael Collison, Saara A Hyatali, Antoniya Kamenova, Adam Rashed, Dylan Riley, Michael R Loebinger

Clin Med (Lond)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiety, depression, physical disease parameters and health-related quality of life in the BronchUK national bronchiectasis cohort.
Anthony De Soyza, Tess Saunders, Georgina Wild, Phil Mawson, Martin Kelly, Michael Loebinger

ERJ Open Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International consensus statement on routine blood testing in primary ciliary dyskinesia.
Sarah Altaraihi, June K Marthin, Pinelopi Anagnostopoulou, Mieke Boon, Siobhan B Carr, Michael R Loebinger

ERJ Open Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis Registry.
Jennifer Pollock, Pieter C Goeminne, Stefano Aliberti, Eva Polverino, Megan L Crichton, Michael R Loebinger

Chest· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement project.
Jamie Cheong, Shereen Boreland, Elaine Shattock, Elaine Bowman, Barbara Belkarty, Michael Loebinger

BMJ Open Qual· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
James D Chalmers, Pierre-Régis Burgel, Charles L Daley, Anthony De Soyza, Charles S Haworth, Michael R Loebinger

N Engl J Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis.
Zina Alfahl, Gisli G Einarsson, J Stuart Elborn, Deirdre F Gilpin, Katherine O'Neill, Michael R Loebinger

Respir Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brensocatib in patients with bronchiectasis: subgroup analyses from the WILLOW trial.
James D Chalmers, Michael R Loebinger, Ariel Teper, Pamela J McShane, Carlos Fernandez

ERJ Open Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated method of bronchus and artery dimension measurement in an adult bronchiectasis population.
Angelina L P Pieters, Qianting Lv, Jennifer J Meerburg, Tjeerd van der Veer, Eleni-Rosalina Andrinopoulou, Michael R Loebinger

ERJ Open Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Tuberculous Mycobacterial Pulmonary Disease-Where are we Now?
Kartik Kumar, Michael R Loebinger

Arch Bronconeumol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts.
Michael R Loebinger, Stefano Aliberti, Charles Haworth, Mateja Jankovic Makek, Christoph Lange

ERJ Open Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype-phenotype correlations.
Johanna Raidt, Sarah Riepenhausen, Petra Pennekamp, Heike Olbrich, Israel Amirav, Michael R Loebinger

Eur Respir J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study.
Angelina L P Pieters, Tjeerd van der Veer, Jennifer J Meerburg, Eleni-Rosalina Andrinopoulou, Menno M van der Eerden, Michael R Loebinger

Am J Respir Crit Care Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Arietta Spinou, Beatriz Hererro-Cortina, Stefano Aliberti, Pieter C Goeminne, Eva Polverino, Michael R Loebinger

Eur Respir J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis